These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7360142)

  • 21. Substrate-specific deoxycytidine kinase deficiency in 1-beta-D-arabinofuranosylcytosine-resistant leukemic cells.
    Richel DJ; Colly LP; Arkesteijn GJ; Arentsen-Honders MW; Kerster MG; ter Riet PM; Willemze R
    Cancer Res; 1990 Oct; 50(20):6515-9. PubMed ID: 2208110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutation at the TK locus of mouse lymphoma L5178Y cells by 4CMB, 4HMB and BC.
    Ross CA; McGregor DB
    Mutat Res; 1982; 100(1-4):249-51. PubMed ID: 7057755
    [No Abstract]   [Full Text] [Related]  

  • 23. Cell killing and mutagenesis by alkylating agents and UV irradiation in wild-type and deoxycytidine-kinase-deficient Friend murine leukaemia cells.
    McKenna PG; Boullier BA
    Mutagenesis; 1988 Mar; 3(2):153-5. PubMed ID: 3288838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of deoxycytidine kinase by 5-azacytidine in an HL-60 cell line resistant to arabinosylcytosine.
    Kong XB; Tong WP; Chou TC
    Mol Pharmacol; 1991 Feb; 39(2):250-7. PubMed ID: 1705001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations resistant to bromodeoxyuridine in mouse lymphoma cells selected by repeated exposure to EMS. Characteristics of phenotypic instability and reversion to HAT resistance by 5-azacytidine.
    Nakamura N; Okada S
    Mutat Res; 1983 Nov; 111(3):353-64. PubMed ID: 6196636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of a multidrug resistant human erythroleukemia cell line (K562) exhibiting spontaneous resistance to 1-beta-D-arabinofuranosylcytosine.
    Grant S; Turner A; Nelms P; Yanovich S
    Leukemia; 1995 May; 9(5):808-14. PubMed ID: 7769843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential for selective enhancement of the in vivo metabolism of 1-beta-D-arabinofuranosylcytosine in rats by thymidine pretreatment.
    Danhauser LL; Rustum YM
    Cancer Res; 1985 May; 45(5):2002-7. PubMed ID: 3986756
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on 1-beta-D-arabinofuranosyl cytosine-resistant mutants of Chinese hamster fibroblasts: III. Joint resistance to arabinofuranosyl cytosine and to excess thymidine--a semidominant manifestation of deoxycytidine triphosphate pool expansion.
    Vincent BR; Buttin G
    Somatic Cell Genet; 1979 Jan; 5(1):67-82. PubMed ID: 432758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular analysis of mutations at the tk locus of L5178Y mouse-lymphoma cells induced by ethyl methanesulphonate and mitomycin C.
    Davies MJ; Phillips BJ; Rumsby PC
    Mutat Res; 1993 Dec; 290(2):145-53. PubMed ID: 7694105
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation and characterization of a 1-beta-D-arabinofuranosylcytosine-resistant Chinese hamster ovary cell mutant that is also X-ray sensitive and is noncomplementary with ataxia telangiectasia cells.
    Preston GA; Payne HS; Preston RJ
    Cancer Res; 1992 Jan; 52(2):319-27. PubMed ID: 1728406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do trifluorothymidine-resistant mutants of L5178Y mouse lymphoma cells re-express thymidine kinase activity following 5-azacytidine treatment?
    Moore MM; Applegate ML; Hozier JC
    Mutat Res; 1988 Feb; 207(2):77-82. PubMed ID: 2448615
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular pharmacodynamic studies of the synergistic combination of 6-mercaptopurine and cytosine arabinoside in human leukemia cell lines.
    Ramilo-Torno LV; Avramis VI
    Cancer Chemother Pharmacol; 1995; 35(3):191-9. PubMed ID: 7805176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of resistance to 1-beta-D-arabinofuranosylcytosine after high-dose treatment in childhood lymphoblastic leukemia: analysis of resistance mechanism in established cell lines.
    Kees UR; Ford J; Dawson VM; Piall E; Aherne GW
    Cancer Res; 1989 Jun; 49(11):3015-9. PubMed ID: 2720661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A mouse-cell mutant sensitive to ionizing radiation is hypermutable by low doses of gamma-radiation.
    Shiomi T; Hieda-Shiomi N; Sato K; Tsuji H; Takahashi EI; Tobari I
    Mutat Res; 1981 Aug; 83(1):107-16. PubMed ID: 7278869
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Isolation and characterization of mutants at the APRT locus in the L-5178Y TK+/TK- mouse lymphoma cell line.
    Paeratakul U; Taylor MW
    Mutat Res; 1986 Mar; 160(1):61-9. PubMed ID: 3951457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of human KB cells resistant to 1-beta-D-arabinofuranosylcytosine, and mechanisms of cellular resistance in isolated clones.
    Tsuruo T; Naganuma K; Iida H; Sone S; Ishii K; Tsubura E; Tsukagoshi S; Sakurai Y
    Gan; 1984 Aug; 75(8):690-8. PubMed ID: 6489676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiproliferative activity and mechanism of action of fatty acid derivatives of arabinofuranosylcytosine in leukemia and solid tumor cell lines.
    Bergman AM; Kuiper CM; Voorn DA; Comijn EM; Myhren F; Sandvold ML; Hendriks HR; Peters GJ
    Biochem Pharmacol; 2004 Feb; 67(3):503-11. PubMed ID: 15037202
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mutational assay system for L5178Y mouse lymphoma cells, using hypoxanthine-guanine-phosphoribosyl-transferase (HGPRT) -deficiency as marker. The occurrence of a long expression time for mutations induced by X-rays and EMS.
    Knaap AG; Simons JW
    Mutat Res; 1975 Oct; 30(1):97-110. PubMed ID: 1237086
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Studies on three mutagen-sensitive mutants of mouse L5178Y cells. II. Complementation analyses between two methyl methanesulfonate-sensitive mutants and between two 4-nitroquinoline-1-oxide-sensitive mutants.
    Shiomi T; Hieda-Shiomi N; Sato K
    Mutat Res; 1982 Aug; 95(2-3):327-37. PubMed ID: 6811890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel mutant of mouse lymphoma cells sensitive to alkylating agents and caffeine.
    Shiomi T; Hieda-Shiomi N; Sato K
    Mutat Res; 1982 Jan; 103(1):61-9. PubMed ID: 7057785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.